Theralase's Covid-19 Vaccine - NewsletterThey are using Theralase's pdt against the COVID-19 virus outside the body and then creating a vaccine using the debris produced by the encounter as raw material.
"...Under the terms of the agreement, Theralase® and PHAC are collaborating on the development and optimization of a Theralase® COVID-19 vaccine by treating the SARS-CoV-2 virus grown on cell lines with Theralase®’s patented PDC and then light activating it with Theralase®’s proprietary TLC-3000A light technology to inactivate the virus and create the fundamental building blocks of a COVID-19 vaccine. This inactivated virus would then be purified and used to inoculate naive animals followed by challenge with the SARS-CoV-2 virus, to ascertain the efficacy of the vaccine. The project is entitled, “Photo Dynamic Compound Inactivation of SARS-CoV-2 Vaccine” and commenced in mid-April 2021."